Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | EPHX1 | P07099 | 7/20 | 0.61 |
| ▸ | PRMT1 | Q99873 | 1/20 | 0.58 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.48 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.48 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.48 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.46 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.46 |
| ▸ | NAAA | Q02083 | 1/20 | 0.45 |
| ▸ | EPHX2 | P34913 | 5/20 | 0.44 |
| ▸ | MEN1 | O00255 | 1/20 | 0.44 |
| ▸ | USP2 | O75604 | 1/20 | 0.44 |
| ▸ | MAPT | P10636 | 1/20 | 0.44 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL194187 | 0.89 | EPHX1 (0.48) | EPHX1PRMT1ALDH1A1EPHX2MEN1 | |
| SCHEMBL31455546 | 0.89 | EPHX1 (0.61) | EPHX1PRMT1KDM4EMAPK1HIF1A | |
| SCHEMBL6824758 | 0.89 | EPHX1 (0.61) | EPHX1PRMT1KDM4EMAPK1HIF1A | |
| SCHEMBL31455527 | 0.89 | EPHX1 (0.61) | EPHX1PRMT1KDM4EMAPK1HIF1A | |
| SCHEMBL17379956 | 0.89 | EPHX1 (0.61) | EPHX1PRMT1KDM4EMAPK1HIF1A | |
| SCHEMBL12495236 | 0.89 | EPHX1 (0.83) | EPHX1NAAAEPHX2 | |
| SCHEMBL8342138 | 0.89 | EPHX1 (0.83) | EPHX1NAAAEPHX2 | |
| SCHEMBL1956274 | 0.89 | EPHX1 (0.50) | EPHX1PRMT1KDM4EMAPK1HIF1A | |
| SCHEMBL10580617 | 0.89 | EPHX1 (0.83) | EPHX1NAAAEPHX2 | |
| SCHEMBL10578502 | 0.89 | EPHX1 (0.83) | EPHX1NAAAEPHX2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-110475840-B | Liquid crystal aligning agent composition, method for producing liquid crystal alignment film, and liquid crystal display device | 株式会社LG化学 | 2023-04-18 | — | — | CN | disclosed |
| US-11592713-B2 | Liquid crystal aligning agent composition, method for preparing liquid crystal alignment film using same, and liquid crystal alignment film and liquid crystal display device using same | LG CHEM, LTD. (KR) | 2023-02-28 | — | — | US | disclosed |
| US-11592713-B2 | Liquid crystal aligning agent composition, method for preparing liquid crystal alignment film using same, and liquid crystal alignment film and liquid crystal display device using same | LG CHEM, LTD. (KR) | 2023-02-28 | — | — | US | disclosed |
| US-10945824-B2 | Mechanism for applying high radial force in less-elastic medical devices | COOK MEDICAL TECHNOLOGIES LLC (US) | 2021-03-16 | — | — | US | disclosed |
| EP-3575381-B1 | LIQUID CRYSTAL ALIGNING AGENT COMPOSITION, METHOD FOR MANUFACTURING LIQUID CRYSTAL ALIGNING FILM USING SAME, LIQUID CRYSTAL ALIGNING FILM USING SAME, AND LIQUID CRYSTAL DISPLAY DEVICE | LG CHEMICAL LTD (KR) | 2020-12-30 | — | — | EP | disclosed |
| EP-3575381-B1 | LIQUID CRYSTAL ALIGNING AGENT COMPOSITION, METHOD FOR MANUFACTURING LIQUID CRYSTAL ALIGNING FILM USING SAME, LIQUID CRYSTAL ALIGNING FILM USING SAME, AND LIQUID CRYSTAL DISPLAY DEVICE | LG CHEMICAL LTD (KR) | 2020-12-30 | — | — | EP | disclosed |
| US-20200392409-A1 | LIQUID CRYSTAL ALIGNING AGENT COMPOSITION, METHOD FOR PREPARING LIQUID CRYSTAL ALIGNMENT FILM USING SAME, AND LIQUID CRYSTAL ALIGNMENT FILM AND LIQUID CRYSTAL DISPLAY DEVICE USING SAME | LG CHEM, LTD. (KR) | 2020-12-17 | — | — | US | disclosed |
| US-20200392409-A1 | LIQUID CRYSTAL ALIGNING AGENT COMPOSITION, METHOD FOR PREPARING LIQUID CRYSTAL ALIGNMENT FILM USING SAME, AND LIQUID CRYSTAL ALIGNMENT FILM AND LIQUID CRYSTAL DISPLAY DEVICE USING SAME | LG CHEM, LTD. (KR) | 2020-12-17 | — | — | US | disclosed |
| EP-3575381-A1 | LIQUID CRYSTAL ALIGNING AGENT COMPOSITION, METHOD FOR MANUFACTURING LIQUID CRYSTAL ALIGNING FILM USING SAME, LIQUID CRYSTAL ALIGNING FILM USING SAME, AND LIQUID CRYSTAL DISPLAY DEVICE | LG CHEM, LTD. (KR) | 2019-12-04 | — | — | EP | disclosed |
| EP-3575381-A1 | LIQUID CRYSTAL ALIGNING AGENT COMPOSITION, METHOD FOR MANUFACTURING LIQUID CRYSTAL ALIGNING FILM USING SAME, LIQUID CRYSTAL ALIGNING FILM USING SAME, AND LIQUID CRYSTAL DISPLAY DEVICE | LG CHEM, LTD. (KR) | 2019-12-04 | — | — | EP | disclosed |
| US-20190015189-A1 | MECHANISM FOR APPLYING HIGH RADIAL FORCE IN LESS-ELASTIC MEDICAL DEVICES | WILMINGTON TRUST, NATIONAL ASSOCIATION, AS COLLATERAL AGENT | 2019-01-17 | — | — | US | disclosed |
| US-10123863-B2 | Mechanism for applying high radial force in less-elastic medical devices | COOK MEDICAL TECHNOLOGIES LLC (US) | 2018-11-13 | — | — | US | disclosed |
| US-20150272752-A1 | MECHANISM FOR APPLYING HIGH RADIAL FORCE IN LESS-ELASTIC MEDICAL DEVICES | WILMINGTON TRUST, NATIONAL ASSOCIATION, AS COLLATERAL AGENT | 2015-10-01 | — | — | US | disclosed |
| US-8137700-B2 | Main chain acid-degradable polymers for the delivery of bioactive materials | U.S. DEPARTMENT OF ENERGY (US) | 2012-03-20 | — | — | US | disclosed |
| US-20090220615-A1 | Main Chain Acid-Degradable Polymers for the Delivery of Bioactive Materials | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA | 2009-09-03 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090220615-A1 | Main Chain Acid-Degradable Polymers for the Delivery of Bioactive Materials | CTSA, GAA, CTSB | EPHX1 706/4885PRMT1 4812/4885KDM4E 3927/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.